- Workflow
Our AI-driven enzyme discovery workflow
From intelligent sequence navigation to lab-ready enzyme panels, we combine AI, bioinformatics, and structural biology to deliver enzymes that perform.
AI powered screening
We use advanced algorithms to filter over 2 billion enzyme sequences scoring each candidate for predicted solubility and activity before anything goes near a lab.
Bioinformatics
Nature holds billions of undiscovered enzyme sequences. Our bioinformatics pipeline analyzes evolutionary relationships and mutational patterns to focus only on the enzyme families relevant to your reaction
Structural biology
Sequence alone doesn't tell the full story. We model enzyme structures in 3D to evaluate substrate compatibility, backbone fit, and potential inhibitors ensuring only the strongest candidates move forward.
Custom enzyme panel
Discovery is only complete when performance is proven in the lab. We deliver your shortlisted enzymes as ready-to-screen panels frozen lysate, lyophilized powder, or cryo-stocks shipped worldwide.
- our services
Benefit from our other services!
- Your Challenges
Solutions tailored to your role
Select your persona and explore the key challenges we solve — each backed by real case studies and linked to our products & services.
Chemist — Drug Discovery
Accelerating Hit-to-Lead with Enzymatic Synthesis
A pharma team reduced their synthesis cycle from 12 weeks to 3 by leveraging our enzyme library for chiral resolution. The biocatalytic approach eliminated toxic metal catalysts and improved stereoselectivity to >99% ee, enabling faster progression of drug candidates into preclinical studies.
Chemist — Process Chemistry
Greener Routes Through Biocatalysis
By replacing a 5-step chemical synthesis with a 2-step enzymatic cascade, a process chemistry group achieved 40% cost reduction and eliminated hazardous reagents. Our engineered transaminases provided the selectivity needed for a key intermediate at multi-kilogram scale.
Chemist — Production at Scale
From Bench to Ton-Scale Manufacturing
Scaling enzymatic reactions from milligrams to metric tons requires robust, production-grade biocatalysts. Our immobilized enzyme technology enabled a client to run continuous-flow production for 6 months without catalyst replacement, achieving consistent >95% conversion.
AI is the solution
Aminoverse's AI platform is the answer to a decade-long struggle: Having engineered enzymes for years, it always bugged me how little knowledge was actually generated and how limited the enzyme's performance were. Unsurprisingly, many enzyme development projects landed in dead ends. We finally change that!